Cedar Hill Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $908K | Sell |
6,800
-22,512
| -77% | -$3.01M | 0.35% | 61 |
|
|
2018
Q3 | $5.58M | Sell |
29,312
-3,240
| -10% | -$617K | 1.25% | 33 |
|
|
2018
Q2 | $5.43M | Sell |
32,552
-4,050
| -11% | -$675K | 1.13% | 36 |
|
|
2018
Q1 | $6.16M | Sell |
36,602
-4,115
| -10% | -$693K | 1.22% | 35 |
|
|
2017
Q4 | $6.66M | Sell |
40,717
-2,119
| -5% | -$347K | 1.16% | 40 |
|
|
2017
Q3 | $8.78M | Sell |
42,836
-1,810
| -4% | -$371K | 1.52% | 27 |
|
|
2017
Q2 | $10.9M | Sell |
44,646
-1,920
| -4% | -$467K | 2.26% | 17 |
|
|
2017
Q1 | $11.1M | Sell |
46,566
-16,745
| -26% | -$4M | 2.32% | 19 |
|
|
2016
Q4 | $13.3M | Buy |
63,311
+9,941
| +19% | +$2.09M | 2.23% | 21 |
|
|
2016
Q3 | $12.3M | Buy |
53,370
+17,182
| +47% | +$3.96M | 2.01% | 24 |
|
|
2016
Q2 | $8.36M | Buy |
+36,188
| New | +$8.36M | 1.44% | 36 |
|